Brief: Egetis Therapeutics 9M Adjusted EPS SEK -0.6
25/11/2025 06:00
Nov 25 (Reuters) - Egetis Therapeutics 9M net income SEK -222.8 million. 9M revenue SEK 44.6 million
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1